Business article - January 14, 2026
JPM 2026: Top Four Business Highlights
This year's JPM business announces include an oncology deal, obesity and radioligand race positioning, and an AI alliance.
Business article - January 9, 2026
PCI Biotech discontinues R&D operations
The company's external evaluation of a new bioprocessing technology has been concluded, with no prospects for further collaboration.
Business article - December 20, 2025
The EU’s new pharmaceutical legislation has been presented
There are welcome improvements but in the major issues around data protection and market exclusivity, the basic conditions for investments in new medicines, the new legislation will unfortunately not strengthen the EU's competitiveness, states SwedenBIO.
Biotech Business - November 18, 2025
Sofinnova announces USD 750M fund that will invest in early stage biotechs
European life science VC firm Sofinnova Partners has announced the close of its latest flagship fund, Sofinnova Capital XI, at EUR 650 million (USD 750 million).
Business article - November 18, 2025
#WAAW: Fighting AMR: Nordic efforts
Antimicrobial resistance is one of the world’s most severe global health threats but there is still hope, including several Nordic innovative solutions.
Business article - October 13, 2025
The Swedish Drug Discovery and Development Pipeline 2026
The fourteenth edition of SwedenBIO's overview of the Swedish pharmaceutical pipeline and the companies driving it has been released, detailing 152 firms engaged in 518 drug discovery and development projects.
